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ABSTRACT 
 
 
 
Fear of cancer recurrence (FCR) is regarded as one of the most common and distressing issues 
affecting cancer survivors. Observational studies have identified several modifiable 
characteristics associated with FCR. However, many of the findings are based on post-hoc 
analyses and come from studies in which FCR was not identified as a primary outcome. This 
study sought to overcome these limitations by using a model comprised of cognitive, behavioral, 
and social characteristics as a framework for examining modifiable characteristics associated 
with FCR. A sample of 120 patients who had been diagnosed with colorectal cancer and 
completed cancer treatment in the past 6 to 36 months was recruited during routine outpatient 
visits or by mail for participation in the study. Medical record reviews were conducted to assess 
clinical variables, and participants filled out a standard demographic questionnaire as well as 
self-report measures of characteristics resistant to modification (perceived risk of recurrence, 
neuroticism, conscientiousness), cognitive modifiable characteristics (self-efficacy, positive 
beliefs about worry, negative beliefs about worry, misinterpretation of symptoms, intolerance of 
uncertainty and rumination), behavioral modifiable characteristics (reassurance seeking and 
health-related reassurance seeking), and social modifiable characteristics (social support and 
social constraints). As hypothesized, results demonstrated that modifiable characteristics (i.e., 
self efficacy, positive beliefs about worry, negative beliefs about worry, intolerance of 
uncertainty, rumination, reassurance seeking, health-related reassurance seeking and social 
constraints) were associated with FCR (all p’s < .05).  Multivariable regression analyses 
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demonstrated that modifiable characteristics accounted for 13% of the variance in FCR beyond 
that accounted for by non-modifiable characteristics (p < .001), with self-efficacy, rumination 
and health-related reassurance seeking accounting for unique variance in FCR. This study has 
identified several modifiable characteristics that should be considered as targets for interventions 
seeking to reduce FCR among cancer survivors. 
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INTRODUCTION 
 
 
 
Fear of cancer recurrence (FCR) is regarded as one of the most common and distressing 
issues affecting cancer survivors (Vickberg, 2003). Studies conducted among patients with 
breast, ovarian, colon, lung or prostate cancer demonstrate that FCR is among the top concerns 
for these survivors (Baker, Denniston, Smith & West, 2005; Fitch, Gray & Franssen, 2000; 
Mehnert, Berg, Henrich & Herschbach, 2009). Furthermore, greater FCR has been associated 
with greater psychological distress, more depressive symptoms, greater anxiety, and poorer 
quality of life (Clayton, Mishel & Belyea, 2006; Skaali et al., 2009; Thewes et al., 2012). 
Additionally, patients with greater FCR tend to use more healthcare services, which likely results 
in greater costs to the healthcare system (Lebel, Tomei, Feldstain, Beattie & McCallum, 2013). 
Studies have identified a number of characteristics associated with fear of recurrence. As 
described below, these characteristics can be divided up into characteristics that are generally 
resistant to modification (e.g., demographic, clinical, and personality characteristics of the 
individual), which will be referred to as “non-modifiable” characteristics, and modifiable 
characteristics (e.g., psychological characteristics of the individual). It is important to distinguish 
between those characteristics that are modifiable versus those that are not so that effective 
interventions can be developed to target the modifiable characteristics associated with FCR. The 
purpose of this study is to identify modifiable characteristics associated with FCR in order to 
inform future development of an intervention. 
Systematic reviews of the literature on FCR have identified a number of non-modifiable 
characteristics related to this construct (Crist & Grunfeld, 2013; Koch, Jansen, Brenner & Arndt, 
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2013; Simard et al., 2013). These reviews have reported that greater FCR is consistently 
associated with younger age, worse disease severity, and more intense treatment (Simard et al., 
2013). For example, a recent study by McGinty and colleagues (2012) found that breast cancer 
survivors who were younger, at a more advanced disease stage and reported greater perceived 
risk of recurrence reported greater FCR. Another study of patients with mixed cancer diagnoses 
found that greater fear of recurrence was associated with more advanced cancer and 
administration of adjuvant chemotherapy (Savard & Ivers, 2013). These findings regarding non- 
modifiable risk characteristics can help clinicians identify those patients who might be most in 
need of an intervention designed to prevent or relieve FCR. However, to determine what 
characteristics should be targeted in such interventions, it is important to identify modifiable 
characteristics associated with FCR. 
With regard to modifiable characteristics, two pertinent lines of research will be 
reviewed: 1) observational studies examining characteristics associated with FCR, and 2) 
intervention studies on FCR. A useful conceptual framework for categorizing and distinguishing 
these modifiable characteristics are cognitive behavioral models of health anxiety and 
generalized anxiety disorder (Dugas, Gagnon, Ladouceur & Freeston, 1998; Dugas, Marchand, 
Ladouceur, 2005; Langlois,& Ladouceur, 2004). These models focus on the impact that thoughts 
and behaviors can have on emotional reactions, like FCR. For example, individuals with 
heightened FCR may be more likely to experience biased cognitions such as misinterpreting 
benign physical symptoms and engage in reassurance seeking behaviors, such as visits to the 
doctor. Social characteristics, such as the availability of social support and a lack of social 
constraints in important relationships, have also been shown to be particularly important for 
successful emotional adjustment to cancer (Lepore, 2001; Lepore & Revenson, 2007). Therefore, 
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the cognitive behavioral model will be expanded upon in this study to include social 
characteristics as well. With this conceptual framework in mind, we review relevant 
observational and interventional research to identify cognitive, behavioral and social 
characteristics that may be related to FCR. 
Observational studies have identified a number of modifiable characteristics associated 
with FCR. In one systematic review of these studies, researchers found that social influences, 
such as family stressors and having fewer significant others were related to greater FCR (Crist & 
Grunfeld, 2013). Other studies have identified behaviors associated with FCR, such as frequent 
visits to the doctors (Lebel et al., 2013; Koch et al., 2014). Additionally, a number of cognitive 
characteristics have also been found to be related to FCR. Having more intrusive thoughts, 
misinterpreting benign physical symptoms, engaging in negative thinking styles, making greater 
use of avoidance coping strategies, using fewer positive reappraisals, and having lower self- 
efficacy are all associated with higher reported fear of recurrence. (Melchior et al., 2013; Myers 
et al., 2013; Park, Cho, Blank, & Wortmann, 2013; Thewes, Bell & Butow, 2013). 
These studies help identify intervention targets worthy of study, such as coping strategies, 
misinterpretation of physical symptoms, reassurance seeking, intrusive thoughts, negative 
thinking styles, the use of cognitive reappraisals, and self-efficacy. However, the studies that 
produced these findings are characterized by a number of limitations. Many of the findings are 
based on post-hoc analyses and many come from studies in which FCR was not identified as a 
primary outcome; consequently, these studies were not specifically designed to assess 
characteristics associated with FCR, nor were their analyses based on a theoretical or conceptual 
model of FCR. Additionally, many of the studies were conducted with only breast cancer 
patients (Melchior et al., 2013; Thewes, Bell & Butow, 2013). Consequently, the generalizability 
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of these findings to survivors of other types of cancer and possible gender differences in FCR are 
unknown. 
The second line of research pertinent to this topic is the intervention literature on FCR. 
To date, only eight studies have been conducted that were designed specifically to test 
interventions for FCR. Two studies evaluated a manualized cognitive-existential intervention for 
FCR. One of these studies by Lebel and colleagues (2014) used a single-arm design to evaluate a 
cognitive-existential group intervention for FCR among 56 women with breast or ovarian cancer 
who reported moderate to high levels of FCR. The other study, by Moran and colleagues (2017), 
used a subset of cancer survivors participating in a larger randomized controlled trial evaluating 
the efficacy of a manualized cognitive-existential intervention to assess one aspect of the 
intervention, the worst case scenario exercise, which was adapted to an individual format. In the 
worst case scenario exercise, participants were asked to write their worst case scenario, then read 
it out-loud every day and rate their anxiety before and after (Moran et al., 2017). One of the 
strengths of these studies is that they used a manualized intervention with content based upon 
two existing theoretical frameworks (Lebel et al., 2014). Specifically, the interventions draw on 
Leventhal’s common sense model (Leventhal, Leventhal & Richard, 1998), which can be used to 
posit that FCR results when internal and external cues (e.g., physical symptoms or medical 
appointments) increase perceived risk of recurrence. Increases in perceived risk of recurrence 
then lead to even more focus on physical symptoms and misinterpretations of them as signs of 
disease recurrence, which, in turn, can lead to maladaptive behaviors such as reassurance 
seeking, excessive worry, avoidance, and body checking (Lebel et al., 2014). Therefore, these 
interventions sought to increase awareness of triggers of FCR, decrease maladaptive coping 
strategies and increase adaptive coping strategies. The interventions also draw on Mishel’s 
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uncertainty in illness theory (Mishel, 1988), which can be used to posit that FCR is heightened 
when individuals are uncertain about the outcome of their illness due to treatment complexity or 
lack of knowledge about which physical symptoms might indicate a recurrence. Therefore, these 
interventions aimed to increase knowledge regarding symptoms of recurrence and increase 
tolerance of uncertainty. Additionally, cognitive models of worry emphasize the function of 
worry as a strategy for avoiding feared outcomes, such as disease recurrence, by interfering with 
emotional processing (Furer, Walker & Freeston, 2001; Ladouceur et al., 2000; Langlois & 
Ladouceur, 2004). To this end, the interventions targeted awareness of FCR, catastrophic 
thoughts about physical symptoms, maladaptive coping strategies, avoidance of feared outcomes, 
beliefs about the benefits of worrying and toleration of uncertainty (Lebel et al., 2014). Authors 
of the first study reported significant improvements on measures of FCR, cancer-specific distress 
and uncertainty (Lebel et al., 2014). However, the study lacked a control group and did not 
examine mediators, limiting the conclusions that can be drawn from the findings. The second 
study by Moran and colleagues (2017) found that higher adherence to the worst case scenario 
homework was significantly related to lower post-intervention FCR. However, this study was 
comprised of a subset of sample participants (53% of the overall sample) who agreed to share 
their homework, lacked a control group and could not isolate the effects of the exercises from the 
overall therapy effects (Moran et al., 2017). 
Two studies to date have examined the efficacy of cognitive behavioral therapy for FCR. 
One of these studies by Herschbach and colleagues (2010), randomly assigned 174 cancer 
patients to either cognitive behavioral group therapy (CBT) or a supportive-experiential group 
therapy (SET), and compared them to a control group recruited one year later. Both interventions 
involved four 90-minutes group sessions. Although a theoretical framework was not identified, 
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the CBT intervention was based on principles of CBT and therefore targeted awareness of fears 
and triggers for FCR, coping strategies and the ability to withstand their fears regarding 
recurrence (Herschbach et al., 2010). The SET intervention was client-centered and non- 
directive, targeting emotional and social support, but allowing patients to choose topics of 
discussion (e.g., coping with illness, partnership and social support; Herschbach et al., 2010). 
Findings showed that fear of progression decreased in both intervention groups as compared to 
the control group (Hershbach et al., 2010). However, participants in the control group were not 
randomized and were recruited at a later time, and mediators were not examined to identify 
effective intervention targets. The other study by van de Wal and colleagues (2017) used a 
randomized controlled trial to evaluate the efficacy of an individual cognitive behavioral 
intervention among 88 breast, prostate or colorectal cancer survivors with high FCR. One of the 
strengths of this study is that it used one existing theoretical framework to inform the 
intervention content (van de Wal et al., 2017). Similar to the study by Lebel and colleagues 
(2014), the intervention draws on the theory proposed by Lee-Jones and colleagues (1997) 
derived from Leventhal’s common sense model (Leventhal, Leventhal & Richard, 1998). 
Therefore, this intervention sought to increase awareness of thoughts, behaviors and emotions 
related to FCR, decrease maladaptive thinking patterns and beliefs about FCR, and increase 
adaptive behavioral responses (van de Wal et al., 2015). The intervention was delivered during 
five face-to-face sessions and three brief online chat or telephone sessions. When compared to 
the usual care group, patients who received the CBT intervention reported significantly less FCR 
and exhibited greater clinically significant improvement in FCR (van de Wal et al., 2017). 
However, the study did not examine mediators nor did it include an active control group, again 
limiting the conclusions that can be drawn from the findings. 
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A single-arm study evaluated a Mindfulness-based Cognitive Therapy (MBCT) group 
intervention for 19 men with advanced prostate cancer (Chambers, Foley, Galt, Ferguson, & 
Clutton, 2012). The intervention addressed the following targets in eight weekly two-hour group 
sessions: intrusive negative thoughts, existential regret, increased hyperarousal and anxiety, 
experiential avoidance, the extent to which treatment side effects were experienced as 
bothersome and illness adjustment (Chambers et al., 2012). The authors reported significant 
improvements on measures of anxiety, avoidance and mindfulness. Additionally, there was a 
non-significant trend for improvement on a measure of FCR (Chambers et al., 2012). However, 
this study included only a single arm, so it is unclear whether the improvements occurred as a 
result of the intervention or due to extraneous factors. Additionally, the investigators did not test 
for mediators, so no conclusions can be drawn about which intervention targets might be 
responsible for changes associated with intervention delivery. 
A study by Dieng and colleagues (2016) evaluated a psychoeducational intervention for 
melanoma cancer survivors in which participants were randomly assigned to the intervention 
comprised of an educational booklet and three individual telephone-based therapy sessions or 
usual care (Dieng et al., 2016). Development of the educational booklet and the therapy sessions 
were based on the Transactional Model of Stress and Coping and core principles of brief 
psychodynamically-oriented psychotherapy. The overall goals of the intervention were to 
understand the participant using empathic listening and to facilitate development of effective 
emotional and behavioral coping skills (Dieng et al., 2015). Beneficial effects were found for the 
intervention group on FCR, stress and melanoma-related knowledge (Dieng et al., 2016). 
However, limited conclusions can be drawn regarding the active ingredient in the treatment 
because the study did not examine mediators, nor did it have an active control group. 
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A study examining the effectiveness of a gratitude intervention on death-related FCR 
included 67 breast cancer survivors randomly assigned to a 6-week online gratitude intervention 
or a 6-week online control condition (Otto, Szczesny, Woriano, Laurenceau & Siegel, 2016). All 
participants were asked to spend 10 minutes writing, with those in the intervention group being 
prompted to write a letter expressing gratitude and those in the control group being prompted to 
list and describe activities they had engaged in recently (Otto, et al., 2016). The intervention was 
hypothesized to exert an influence on FCR through increases in positive affect and weekly goal 
pursuit, which were included as mediators in the analyses (Otto et al., 2016). Several models 
were cited as informing the intervention’s proposed mechanisms of change including 
Fredrickson’s broaden-and-build theory of positive emotions, terror management theory and 
meaning management theory (Otto et al., 2016). Findings demonstrated beneficial effects on 
death worry which was mediated by meaningful goal pursuit, but no significant changes in FCR 
were found (Otto et al., 2016). Although this study included an active control group and 
examined mediators, it did not find significant effects on overall FCR. 
A more recent study by Lichtenthal and colleagues (2017) examined the efficacy of a 
computerized cognitive bias modification intervention named the Attention and Interpretation 
Modification for Fear of Breast Cancer Recurrence (AIM-FBCR). The AIM-FBCR was based on 
cognitive models of anxiety which posit that cognitive biases, including attention to threat- 
relevant stimuli and interpreting uncertainty in a threatening manner, are involved in the 
development and maintenance of anxiety (Lichtenthal et al., 2017). One-hundred and ten breast 
cancer survivors were randomly assigned to complete the AIM-FBCR intervention, which 
involved completion of an attention modification task and an interpretation modification task, or 
a control condition, which involved completion of a similar task without providing reinforcement 
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aimed at modifying attention or interpretation of stimuli (Lichtenthal et al., 2017). Beneficial 
effects were found for interpretation cognitive biases and health worries, but not overall FCR 
(Lichtenthal et al., 2017). However, interpretation of results is limited because the study did not 
test for mediation. 
Results of these studies are promising, but there are several limitations. Only two of the 
studies had an appropriate control group and neither of the studies with active control groups 
demonstrated beneficial effects on overall FCR. In addition, only one of these studies conducted 
mediational analyses to evaluate whether or not intervention components changed intended 
targets, and thereby contributed to improvements in FCR. However, these studies do help 
identify intervention targets worthy of study, such as intrusive worry, maladaptive thoughts 
about physical symptoms, maladaptive coping strategies (such as excessive reassurance seeking), 
beliefs about the benefits of worry, toleration of uncertainty, and social support. 
To summarize with regard to non-modifiable characteristics (including ones that are 
generally resistant to modification), potential contributors to FCR include age, disease severity, 
treatment intensity, perceived risk of recurrence and personality characteristics. Interventions 
targeting perceived risk have been largely unsuccessful in altering risk perceptions (Lipkus et al., 
2004; Robb, Campbell, Evans, Miles & Wardle, 2008). Two personality traits, neuroticism and 
conscientiousness will be included as non-modifiable characteristics. Personality traits persist 
across situations and time, and are generally not considered modifiable. Neuroticism has been 
associated with fear of cancer recurrence, as well as other mental health problems (Lahey, 2009). 
Additionally, conscientiousness has been associated with compulsive checking and generalized 
anxiety disorder (Rosellini & Brown, 2011; Sher, Rossy & Bishop, 2000). Therefore, this study 
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examined the following non-modifiable characteristics for their relationship with FCR: 
neuroticism, conscientiousness, perceived risk of recurrence, age, and disease severity. 
To summarize with regard to cognitive characteristics, those identified as contributors or 
potential contributors to FCR in the literature include misinterpretation of physical symptoms, 
beliefs about the benefit of worry, toleration of uncertainty, negative thinking styles (e.g., 
rumination), the use of avoidance coping strategies, using fewer positive reappraisals, and lower 
self-efficacy. In addition, research evaluating cognitive behavioral models of generalized anxiety 
disorder and health anxiety has identified intolerance of uncertainty, misinterpretation of 
symptoms, and beliefs about the benefit of worry as key characteristics contributing to intrusive 
worry and subsequent anxiety (Dugas et al., 1998; Dugas, Marchand, Ladouceur, 2005; 
Langlois,& Ladouceur, 2004). Research among cancer patients has also found that intolerance of 
uncertainty is related to psychological distress (Eisenberg et al., 2014; Kurita, Garon, Stanton & 
Meyerowitz, 2013), and that the misinterpretation of benign symptoms is a key contributor to 
FCR (Mehnert, Berg, Henrich & Herschbach, 2009; Lee-Jones, Humphris, Dixon & Hatcher, 
1997). Therefore, this study examined the following cognitive characteristics for their 
relationship with FCR: self-efficacy for preventing a cancer recurrence, positive beliefs about the 
benefits of worry, negative beliefs about the danger and uncontrollability of worry, 
misinterpretation of symptoms, intolerance of uncertainty, and rumination. 
To summarize with regard to behavioral characteristics, the literature on behaviors 
associated with FCR points to the importance of reassurance seeking behaviors in contributing to 
greater FCR. Additionally, intervention studies targeting reassurance seeking have demonstrated 
reductions in FCR (Lebel et al., 2014). Cognitive behavioral models of health anxiety also 
emphasize the importance of health-related reassurance seeking behaviors, such as visiting the 
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doctor, in maintaining health anxiety (Furer, Walker & Freeston, 2001; Langlois & Ladouceur, 
2004). Furthermore, studies on FCR have found that survivors with greater FCR visit the doctor 
more frequently (Lebel, 2013; Koch, 2014). Therefore, health-related reassurance seeking 
behaviors were examined in the current study for their relationship with FCR. Additionally, 
threat-related reassurance seeking behaviors were assessed to determine whether FCR is related 
to the tendency to engage in reassurance seeking specific to health or occurs more generally to 
the tendency to engage in reassurance seeking in response to any type of threat. 
To summarize with regard to social characteristics, observational studies demonstrate that 
social influences, such as family stressors and having fewer significant others are associated with 
FCR (Crist & Grunfeld, 2013). In addition, an intervention that targeted social support led to 
reduced FCR (Hershbach et al., 2010). Furthermore, a large body of literature on psychological 
distress in cancer patients has shown that the availability of social support and a lack of social 
constraints in important relationships are important for successful emotional adjustment to 
cancer (Lepore, 2001). Therefore, social support and social constraints were examined in this 
study for their relationship with FCR. 
In conclusion, this study used a model comprised of cognitive, behavioral, and social 
characteristics as a framework for examining modifiable characteristics associated with FCR. 
This is consistent with research on cognitive behavioral models of health anxiety and generalized 
anxiety disorder, as well as the literature on FCR. The focus was on survivors of colorectal 
cancer who had completed treatment in the past 6 to 36 months. This patient population was 
selected for several reasons. First, colorectal cancer is the third most common cancer and third 
leading cause of cancer mortality in the U.S. (Siegel, DeSantis & Jemal, 2014). Second, studies 
show that FCR is a common and distressing concern among colorectal cancer survivors (Simard 
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& Savard, 2009; Taylor, Richardson, Cowley, 2011). Third, an advantage of studying colorectal 
cancer survivors is that it affects both males and females, so both genders will be represented in 
the study. 
 
 
Aims of the Current Study 
 
The overall aim of the current study was to identify modifiable characteristics associated 
with FCR in order to inform the future creation of an intervention for cancer survivors 
experiencing clinically meaningful FCR. Additionally, the study sought to evaluate the relative 
contributions of modifiable and non-modifiable characteristics to FCR. 
 
 
 
Aim 1 
 
To characterize non-modifiable characteristics associated with FCR. 
 
Hypothesis Set 1. It was hypothesized that greater FCR would be associated with greater 
neuroticism, greater conscientiousness, greater perceived risk, younger age and worse disease 
severity. 
 
 
 
Aim 2 
 
To identify modifiable behavioral, cognitive and social characteristics associated with 
 
FCR. 
 
Hypothesis Set 2. It was hypothesized that greater FCR would be associated with less 
self-efficacy for preventing a cancer recurrence, more positive beliefs about worry, more 
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negative beliefs about worry, more misinterpretation of symptoms, less tolerance of uncertainty 
and more rumination (cognitive characteristics). 
Hypothesis Set 3. It was hypothesized that greater FCR would be associated with more 
frequent threat-related and health-related reassurance seeking (behavioral characteristics). 
Hypothesis Set 4. It was hypothesized that greater FCR would be associated with less 
social support and greater social constraints (social characteristics). 
 
 
Aim 3 
 
To determine the relative contributions of behavioral, cognitive, and social characteristics 
to FCR after accounting for non-modifiable characteristics (i.e., demographic, clinical, and 
personality characteristics). Toward this end, the study examined whether or not modifiable 
characteristics account for variance in FCR above and beyond that accounted for by non- 
modifiable characteristics, and if so, what distinct contributions each modifiable factor makes to 
the variance explained 
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METHODS 
 
 
Participants 
 
Participants were patients who met the following eligibility criteria: 1) diagnosed with 
stage I-III colorectal cancer, 2) completed treatment for colorectal cancer in the past 6-36 
months, 3) no clinical evidence of disease at the time of recruitment, 4) no history of cancer 
recurrence 5) not diagnosed with any other form of cancer except non-melanoma skin cancer, 6) 
able to read and speak English, 7) 18 years of age or older, and 8) able to provide informed 
consent. In order to ensure adequate representation of males and females, patients were recruited 
such that at least 40% of the sample would be either male or female. 
 
 
Procedure 
 
After a review of medical records for initial screening, potentially eligible patients were 
approached during a scheduled follow-up visit in the Moffitt Cancer Center Gastrointestinal 
Oncology Clinic to have the study protocol explained. If eligible and interested, participants 
were asked to sign an IRB-approved informed consent form. They were then given the option of 
filling out the study measures during their outpatient visit, taking them home and returning the 
completed measures in a self-addressed stamped envelope, or completing the measures at home 
via a secure web-based survey. Patients identified as eligible but not scheduled to come in for a 
follow-up appointment within the next three months were contacted by phone or e-mail to 
determine if they were eligible and interested in participating in the study. Those who expressed 
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interest were mailed a packet containing an IRB-approved informed consent form, a study 
questionnaire, and a postage paid return envelope. If patients preferred to complete the study 
online, instructions for accessing a secure web-based survey were e-mailed to them for 
completion. 
 
 
Measures 
 
Measures of Non-Modifiable Characteristics 
 
Demographic characteristics. The following demographic characteristics were assessed 
using a standardized self-report form: age, gender, race, ethnicity, marital status, income, 
employment status, number of minor children, and education. 
Clinical characteristics. The following clinical characteristics were assessed by 
conducting a medical chart review: cancer site, cancer stage at diagnosis, date of diagnosis, 
date(s) of treatment(s), and type(s) of treatment(s), date(s) of cancer surveillance tests, 
genetic/inherited risk factors. 
Perceived Risk. Perceived risk of cancer recurrence was assessed using participants’ 
estimates of their absolute and comparative risk with items adapted from prior research 
(Valdimarsdottir et al., 1995). To assess absolute risk participants were asked, “How likely do 
you think you are to have colorectal cancer again during your lifetime?” To assess comparative 
risk participants were asked, “What do you think your chances are of having colorectal cancer 
again in your lifetime compared to other individuals your age with colorectal cancer who 
received the same treatment for the same type of colorectal cancer? The absolute risk item was 
rated on a six-point response scale from 1 = extremely unlikely to 6 = extremely likely, and the 
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comparative risk item was rated on a five-point scale from 1 = much higher to 5 = much lower. 
Absolute and comparative risk scores were converted to the same metric and then summed to 
create a total perceived risk score. This measure has demonstrated adequate internal 
consistency with a Cronbach’s alpha of 0.79 (McGinty, Goldenberg & Jacobsen, 2012). In the 
present study, this measure demonstrated marginal internal consistency reliability (α = .65), 
which is not inconsistent with its length. 
Neuroticism. Neuroticism was assessed using the neuroticism subscale of the NEO 
Five- Factor Inventory-3 (NEO-FFI-3; McCrae & Costa, 2004). The neuroticism subscale is 
comprised of 12 items that are rated on a five-point response scale ranging from 0 = strong 
disagreement to 4 = strong agreement. The NEO-FFI-3 has demonstrated good convergent 
validity with other validated measures of pathological worry and trait anxiety and adequate 
internal consistency reliability, with a Cronbach’s alpha ranging from 0.82 to 0.88 (McCrae & 
Costa, 2004). In the present study, this subscale demonstrated adequate internal consistency 
reliability (α = .88). 
Conscientiousness. Conscientiousness was assessed using the conscientiousness 
subscale of the NEO-FFI-3 (McCrae & Costa, 2004). The conscientiousness subscale is 
comprised of 12 items that are rated on a five-point response scale ranging from 0 = strong 
disagreement to 4 = strong agreement. The NEO-FFI-3 has demonstrated good convergent 
validity with other validated measures of pathological worry and trait anxiety and adequate 
internal consistency reliability, with a Cronbach’s alpha ranging from 0.79 to 0.87 (McCrae & 
Costa, 2004). In the present study, this subscale demonstrated adequate internal consistency 
reliability (α = .87). 
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Measures of Cognitive Characteristics 
 
Self-Efficacy. Self-efficacy for preventing a cancer recurrence was assessed using one 
item adapted from prior research (Clark & Dodge, 1999). Participants were asked, “How 
confident are you that you can do things to prevent a cancer recurrence?” This item was rated on 
a ten-point scale from 1 = not at all confident to 10 = very confident. 
Positive Beliefs about Worry. Positive beliefs about worry was assessed using the 
positive beliefs about worry subscale of the 30-item Metacognitions Questionnaire (MCQ-30; 
Wells & Cartwright-Hatton, 2004). The positive beliefs subscale is comprised of six items that 
are rated on a four-point response scale ranging from 1 = do not agree to 4 = agree very much. 
The positive beliefs subscale has demonstrated good convergent validity with other validated 
measures of pathological worry and trait anxiety and adequate internal consistency reliability, 
with a Cronbach’s alpha of 0.92 (Wells & Cartwright-Hatton, 2004). In the present study, this 
subscale demonstrated adequate internal consistency reliability (α = .91). 
Negative Beliefs about Worry. Negative beliefs about worry was assessed using the 
negative beliefs about the danger and uncontrollability of worry subscale of the 30-item 
Metacognitions Questionnaire (MCQ-30; Wells & Cartwright-Hatton, 2004). This subscale is 
comprised of six items that are rated on a four-point response scale ranging from 1 = do not 
agree to 4 = agree very much. The negative beliefs subscale has demonstrated good convergent 
validity with other validated measures of pathological worry and trait anxiety and adequate 
internal consistency reliability, with a Cronbach’s alpha of 0.89 (Wells & Cartwright-Hatton, 
2004). In the present study, this subscale demonstrated adequate internal consistency reliability 
(α = .87). 
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Misinterpretation of Symptoms. Misinterpretation of bodily symptoms was assessed 
using the Multidimensional Inventory of Hypochondriacal Traits (MIHT) hypochondriacal 
absorption subscale (Longley, Watson & Noyes, 2005). The nine-item MIHT hypochondriacal 
absorption subscale asks respondents to rate items on a five-point scale ranging from 1 = 
strongly disagree/definitely false to 5 = strongly agree/definitely true. The subscale has 
demonstrated good concurrent validity with validated measures of hypochondriacal cognitions, 
and adequate internal consistency reliability, with Cronbach’s alpha ranging from 0.81 to 0.86 
(Longley, Watson & Noyes, 2005). In the present study, this subscale demonstrated adequate 
internal consistency reliability (α = .87). 
Intolerance of Uncertainty. Intolerance of uncertainty was assessed using the 27-item 
Intolerance of Uncertainty Scale (IUS; Buhr & Dugas, 2002). Items are rated on a five-point 
scale ranging from 1 = not at all characteristic of me to 5 = entirely characteristic of me. The 
IUS has demonstrated good convergent validity with validated measures of worry, depression, 
and anxiety, and adequate internal consistency reliability, with a Cronbach’s alpha of 0.94 (Buhr 
& Dugas, 2002). In the present study, this measure demonstrated adequate internal consistency 
reliability (α = .95). 
Rumination. Rumination was assessed using the Rumination-Reflection Questionnaire 
(RRQ) rumination subscale (Trapnell & Campbell, 1999). The 12-item rumination subscale asks 
participants to indicate their level of agreement or disagreement with items on a five-point 
response scale ranging from 1 = strongly disagree to 5 = strongly agree. The rumination 
subscale has demonstrated good convergent validity with validated measures of neuroticism and 
depression, and adequate internal consistency reliability, with Cronbach’s alpha ranging from 
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0.88 to 0.90 (Siegle, Moore & Thase, 2004; Trapnell & Campbell, 1999). In the present study, 
this measure demonstrated adequate internal consistency reliability (α = .91). 
 
 
 
Measures of Behavioral Characteristics 
 
Threat-related Reassurance Seeking. Reassurance seeking behavior was assessed using 
the Threat-related Reassurance Seeking Scale (TRSS). The TRSS is an eight-item measure that 
asks about an individual’s tendency to engage in reassurance seeking behaviors (Cougle et al., 
2012). Respondents rate each item on a seven-point scale from 1 = no, not at all to 7 = yes, very 
much. The scale has been shown to have good convergent validity with a validated measure of 
depressive reassurance seeking and acceptable internal consistency reliability, with Cronbach’s 
alpha of 0.93 (Cougle et al., 2012). In the present study, this measure demonstrated adequate 
internal consistency reliability (α = .94). 
Health-related Reassurance Seeking. Health-related reassurance seeking behavior was 
assessed using the Multidimensional Inventory of Hypochondriacal Traits (MIHT) 
hypochondriacal reassurance subscale (Longley, Watson & Noyes, 2005). The MIHT 
hypochondriacal reassurance subscale is comprised of eight items that are rated on a five-point 
scale. Respondents rate items on a scale from 1 = strongly disagree/definitely false to 5 = 
strongly agree/definitely true. The measure has been shown to have good concurrent validity 
with other validated measures of hypochondriacal behavior and adequate internal consistency 
reliability, with Cronbach’s alpha ranging from 0.82 to 0.86 (Longley, Watson & Noyes, 2005). 
In the present study, this subscale demonstrated adequate internal consistency reliability (α = 
.89). 
20  
 
 
 
Measures of Social Characteristics 
 
Social Support. Social support was assessed using the 12-item Interpersonal Support 
Evaluation List (ISEL-12). The ISEL-12 is comprised of three subscales, appraisal, belonging 
and tangible support (Cohen, 2008). Respondents rate items on a four-point scale from 1 = 
definitely false, to 4 = definitely true. The scale has demonstrated good concurrent validity with 
other validated measures of social support, and adequate internal consistency reliability, with 
Cronbach’s alpha ranging from 0.80 to 0.90 (Cohen, 2008). In the present study, this measure 
demonstrated adequate internal consistency reliability (α = .93). 
Social Constraints. The degree of relationship strain was assessed using the 15-item 
Social Constraints Scale (SCS-15). This scale asks about the degree of strain individuals 
experience with the most important person in their life (Lepore, Silver, Wortman & Wayment, 
1996). Respondents rate items on a four-point scale from 1 = never to 4 = often. This scale has 
demonstrated good convergent validity among cancer patients with validated measures of 
cancer-related distress, and adequate internal consistency reliability, with Cronbach’s alpha 
ranging from 0.85 to 0.95 (Lepore et al., 1996; Lepore & Revenson, 2007). In the present study, 
this measure demonstrated adequate internal consistency reliability (α = .94). 
 
 
 
Outcome Measure 
 
Fear of Cancer Recurrence. FCR was assessed using the 42-item Fear of Cancer 
Recurrence Inventory (FCRI; Simard & Savard, 2009). The FCRI includes the following 
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subscales: triggers, severity, psychological distress, coping strategies, functioning impairments, 
insight, and reassurance (Simard & Savard, 2009). It has demonstrated good convergent validity 
with measures of psychological distress and quality of life, and adequate internal consistency 
reliability with Cronbach’s alpha of 0.95 (Simard & Savard, 2009). The severity subscale served 
as the main outcome variable, as it is highly related (r = 0.84) to the total FCRI score (Simard & 
Savard, 2009). In the present study, the total FCRI scale (α = .92) and the severity subscale (α = 
.81) demonstrated adequate internal consistency reliability. 
 
 
 
Statistical Analyses 
 
Prior to conducting the main analyses, descriptive statistics were computed for 
demographic, clinical and psychological characteristics to characterize the study sample. Log 
transformations were computed for those variables demonstrating skewness as defined by 
kurtosis less than -1 or greater than 1. However, after performing the main analyses with both 
untransformed and log transformed variables and obtaining similar findings with regard to 
statistical significance, it was decided to report results using the untransformed variable to retain 
the interpretability of results. Sporadic missing data points (n = 33) were addressed using sample 
mean imputation. 
The first aim was to identify non-modifiable characteristics associated with fear of 
recurrence and hypothesis set 1 asserts that greater FCR would be associated with greater 
neuroticism, greater conscientiousness, greater perceived risk, younger age and worse disease 
severity. To test this hypothesis, Pearson’s r correlations were calculated to determine if there 
were significant relationships between FCR as measured by the FCRI, and neuroticism, 
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conscientiousness, perceived risk, age and disease severity, as well as gender for which no 
hypothesis was offered. 
The second aim was to identify modifiable behavioral, cognitive and social modifiable 
characteristics associated with FCR. Hypothesis set 2 asserts that greater FCR would be 
associated with less self-efficacy for preventing a cancer recurrence, more positive beliefs about 
worry, more negative beliefs about worry, more misinterpretation of symptoms, less intolerance 
of uncertainty and more rumination (cognitive characteristics). Pearson’s r correlations were 
calculated to determine if there were significant relationships between FCR as measured by the 
FCRI and self-efficacy, positive beliefs about worry as measured by the MCQ-30 positive beliefs 
subscale, negative beliefs about worry as measured by the MCQ-30 negative beliefs about the 
danger and uncontrollability of worry subscale, misinterpretation of symptoms as measured by 
the MIHT hypochondriacal absorption subscale, and intolerance of uncertainty as measured by 
the IUS. Hypothesis set 3 asserts that greater FCR would be associated with more frequent 
threat-related and health-related reassurance seeking (behavioral characteristics). Pearson’s r 
correlations were calculated to determine if there were significant relationships between FCR as 
measured by the FCRI, and threat-related and health-related reassurance seeking behaviors as 
measured by the TRSS and MIHT hypochondriacal subscale, respectively. Hypothesis set 4 
states that greater FCR would be associated with less social support and greater social constraints 
(social characteristics). Pearson’s r correlations were calculated to determine if there were 
significant relationships between FCR, as measured by the FCRI and social support, as measured 
by the ISEL-12, and social constraints, as measured by the SCS-15. 
The third aim was to determine the relative contributions of behavioral, cognitive, and 
social characteristics to FCR after accounting for non-modifiable characteristics (i.e., 
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demographic, clinical, and personality characteristics). To achieve this aim, hierarchical multiple 
linear regression analyses were conducted. Measures of non-modifiable characteristics that were 
found to be significantly correlated with FCR were entered into the analysis on the first step. 
Measures of the behavioral, cognitive and social characteristics that were found to be 
significantly correlated with FCR were entered into the model simultaneously in a subsequent 
step. Change in R2 was used to determine whether or not the modifiable characteristics account 
for variance above that accounted for by non-modifiable characteristics. In addition, p-values 
were examined to determine which modifiable variables accounted for the most unique variance 
in FCR. 
A power analysis was conducted using G*Power (Faul, Erdfelder, Lang & Buchner, 
2007) to determine the number of participants needed to detect a Pearson’s r = 0.30 (medium 
effect size) with a power of 80% and an alpha = .05 (two-tailed). It was determined that a total 
sample size of 84 participants would be needed. A second power analysis was conducted to 
determine the number of participants needed to obtain power of .80 using multiple linear 
regression with an alpha = .05 (two-tailed) to detect an effect size in which two covariates (i.e., 
non-modifiable characteristics) initially account for 5% of the outcome variance, and upwards of 
four cognitive, behavioral or social characteristics account for 9% of the remaining variance in 
FCR. It was determined that 120 participants would be needed. Therefore, the current study 
enrolled and obtained data on 120 participants. 
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RESULTS 
 
 
 
Participants 
 
Participant flow is shown in Figure 1. One thousand four hundred eighty-six patients 
were screened for this study; of these, 1,239 were ineligible based on medical record reviews 
(e.g., no colorectal cancer, stage IV or metastatic disease, history of cancer recurrence, history of 
other cancer diagnosis) and 49 were unable to be contacted by phone or were not scheduled for a 
follow-up appointment. The remaining 198 participants were approached for participation; of 
these, 41 refused to participate, and 17 verbally agreed to participate but never signed consent. 
One hundred forty patients signed consent (71% of those able to be contacted). Of those who 
consented, 13 never completed the study measures and could not be reached, 3 were found to be 
ineligible after they consented, and 4 withdrew their consent. Thus, analyses were conducted on 
the 120 patients who had evaluable data. Thirty-one percent of participants completed the online 
version, while 69% completed the written version of the study questionnaire. 
Participant demographic and clinical characteristics are shown in Table 1. Participants 
ranged in age from 33 to 94 years (M = 61.28; SD = 12.54). The majority were college-educated 
(82%), currently employed (52%), female (51%), married (61%), White (93%) and did not have 
minor children (81%). Seventy-seven patients (64%) were diagnosed with rectal cancer and 43 
(36%) were diagnosed with colon cancer. On average, participants were 25.45 months (SD = 
11.17) from their original cancer diagnosis, 17.46 months (SD = 9.60) from their most recent 
cancer treatment, and 2.56 months (SD = 4.13) from their most recent cancer surveillance test. 
25  
Thirty-six participants (30%) had surgery only, 22 (18%) had surgery and chemotherapy, four 
(3%) had radiation and chemotherapy, and 58 (48%) had surgery, chemotherapy and radiation. 
Four patients (3%) had Lynch Syndrome, an inherited condition associated with increased risk 
for colorectal cancer. 
Participant scores on the primary outcome, the FCRI severity subscale, ranged from one 
to 30 (M = 14.13; SD = 6.50). Using an empirically validated cut-off score of 13, 67 participants 
(56%) were identified as meeting criteria for clinically significant FCR (Simard & Savard, 
2015). 
Participants (n = 120) were compared to non-consenters (n = 58; i.e., those who were 
approached but did not provide written consent) on demographic characteristics. Participants 
were significantly more likely to be white than non-consenters (p < .05). There were no 
significant differences between participants (n = 120) and those who failed to complete measures 
(n = 13) on demographic characteristics. 
 
 
Relationships between Non-Modifiable Characteristics and Fear of Cancer Recurrence 
 
To address Aim 1, Pearson’s r correlations were conducted to determine if FCR was 
related to perceived risk, age, disease severity, neuroticism and conscientiousness (see Table 2). 
As hypothesized, age, disease severity and neuroticism were associated with FCR in the 
expected direction (all p values < .05).  That is, younger age, worse disease severity and greater 
neuroticism were related to higher levels of FCR. Contrary to hypotheses, perceived risk of 
cancer recurrence was not related to FCR. Conscientious was associated with FCR, but not in the 
expected direction (p < .05), in that lower levels of conscientiousness were related to greater 
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FCR. Additionally, it was found that gender was associated with FCR, such that females reported 
greater FCR (p < .01). 
 
 
Relationships between Modifiable Characteristics and Fear of Cancer Recurrence 
 
To address Aim 2, Pearson’s r correlations were conducted to determine if FCR was 
related to modifiable behavioral, cognitive and social characteristics (see Table 3). 
 
 
Cognitive Characteristics 
 
Consistent with hypothesis set 2, self-efficacy for preventing a cancer recurrence, 
positive beliefs about worry, negative beliefs about worry, intolerance of uncertainty and 
rumination were related to FCR in the expected direction (all p values < .05). That is, less self- 
efficacy for preventing a cancer recurrence, more positive beliefs about worry, more negative 
beliefs about worry, more intolerance of uncertainty and more rumination were associated with 
greater FCR. In contrast, misinterpretation of symptoms was not related to FCR (p = .86). 
 
 
Behavioral Characteristics 
 
Consistent with hypothesis set 3, threat-related reassurance seeking and health-related 
reassurance seeking were related to FCR in the expected direction (p values < .001). That is, 
greater threat-related and greater health-related reassurance seeking were related to greater FCR 
(p values < .001). 
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Social Characteristics 
Consistent with hypothesis set 4, social constraints were related to FCR in the expected 
direction (p < .01) such that greater social constraints were associated with greater FCR (see 
Table 3). However, contrary to expectation, social support was not related to FCR (p = .38). 
 
 
 
Non-Modifiable and Modifiable Contributors to Fear of Cancer Recurrence 
 
In order to determine the relative contributions of behavioral, cognitive, and social 
characteristics to FCR after accounting for non-modifiable characteristics (i.e., demographic, 
clinical, and personality characteristics) hierarchical multiple linear regression analyses were 
conducted. Measures of non-modifiable characteristics that were found to be significantly 
correlated with FCR were entered into the analysis on the first step (i.e., age, gender, disease 
severity, neuroticism and conscientiousness) and measures of the modifiable characteristics that 
were found to be significantly correlated with FCR were entered into the model simultaneously 
in a subsequent step (i.e., self-efficacy for preventing a cancer recurrence, positive beliefs about 
worry, negative beliefs about worry, intolerances of uncertainty, reassurance seeking, health- 
related reassurance seeking and social constraints). Multicollinearity statistics did not indicate 
the presence of significant intercorrelations (i.e., VIF > 4, see Table 4). Step one of the 
regression analysis that comprised non-modifiable characteristics (i.e., age gender, disease 
severity, neuroticism and conscientiousness) was statistically significant (ΔR2 = .33, F(5, 114) = 
11.19, p <.001). Addition of modifiable characteristics (i.e., self-efficacy for preventing a cancer 
recurrence, positive beliefs about worry, negative beliefs about worry, intolerance of uncertainty, 
reassurance seeking, health-related reassurance seeking and social constraints) in step two 
significantly increased the amount of variance accounted for by the model beyond what was 
accounted for by the non-modifiable characteristics alone (ΔR2 = .13, F(13, 106) = 6.96, p 
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<.001). Among the modifiable characteristics, self-efficacy for preventing a cancer recurrence (B 
 
= -.554; p < .05), rumination (B = .157; p < .05), and health-related reassurance seeking (B = 
 
.194; p < .05) significantly accounted for unique variance in FCR, such that less self-efficacy for 
preventing a cancer recurrence, greater rumination and greater health-related reassurance seeking 
were related to greater FCR. 
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Table 1 
 
 
Participant demographic and clinical characteristics 
 
 
Characteristic 
 
Mean (SD)/ N (%) 
Age (in years) 61.28 (12.54) 
Female 61 (51) 
White 111 (93) 
Non-Hispanic 109 (91) 
Married 73 (61) 
Years of education  
12 or less 22 (18) 
13 to 16 72 (60) 
17 or more 26 (22) 
Current employment  
Working 62 (52) 
On leave 4 (3) 
Not employed 53 (44) 
Annual gross income  
< $40,000 33 (28) 
$40,000-$100,000 52 (43) 
>$100,000 25 (21) 
Cancer site  
Rectal 77 (64) 
Colon 43 (36) 
Cancer stage at diagnosis  
I 33 (28) 
II 41 (34) 
III 46 (38) 
Lynch Syndrome 4 (3) 
Time since diagnosis (in months) 25.45 (11.17) 
Treatment type  
Surgery 36 (30) 
Surgery + chemotherapy 22 (18) 
Radiation + chemotherapy 4 (3) 
Surgery + chemotherapy + radiation 58 (48) 
Time since most recent treatment (in months) 17.46 (9.60) 
Time since most recent cancer surveillance (in months) 2.56 (4.13) 
N = 120 
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Table 2 
 
Correlations of non-modifiable characteristics with the Fear of Cancer Recurrence Inventory 
Severity Subscale 
 
Non-modifiable characteristics FCRI 
Perceived risk .12 
Age -.36*** 
Gender .26** 
Disease severity .18* 
Neuroticism (NEO-FFI-3) .41*** 
Conscientiousness (NEO-FFI-3) -.22* 
* p < .05, **p < .01, *** p < .001 
Note: FCRI = Fear of Cancer Recurrence Inventory; NEO-FFI-3 = NEO Five-Factor Inventory-3 
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Table 3 
 
Correlations of modifiable characteristics with the Fear of Cancer Recurrence Inventory 
Severity Subscale 
 
Modifiable characteristics FCRI 
Cognitive characteristics  
Self-efficacy -.41*** 
Positive beliefs about worry 
(MCQ-30) 
.22* 
Negative beliefs about worry 
(MCQ-30) 
.32*** 
Misinterpretation of symptoms 
(MIHT) 
-.02 
Intolerance of uncertainty 
(IUS) 
.30*** 
Rumination (RRQ) .45*** 
Behavioral characteristics  
Reassurance seeking (TRSS) .34*** 
Health-related reassurance 
seeking (MIHT) 
.37*** 
Social characteristics 
 
Social support (ISEL-12) -.08 
Social constraints (SCS) .28** 
* p < .05, **p < .01, *** p < .001 
Note: FCRI = Fear of Cancer Recurrence Inventory; MCQ-30 = Metacognitions Questionnaire; 
MIHT = Multidimensional Inventory of Hypochondriacal Traits; IUS = Intolerance of 
Uncertainty Scale; RRQ = Rumination-Reflection Questionnaire; TRSS = Threat-related 
Reassurance Seeking Scale; ISEL-12 = Interpersonal Support Evaluation List; SCS = Social 
Constraints Scale 
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Table 4 
 
Two-step hierarchical linear regression 
 
 B SE β t (p-value) Δ R2 (p- 
value) 
VIF Mode 
l Adj 
R2 
Step 1  5.44   .33 (<.001)  .30 
Gender .46 1.04 .04 .45 (.66)  1.26  
Age -.16 .04 -.30 -3.77 (<.001)  1.24  
Disease severity .37 .22 .13 1.65 (.10)  1.15  
Neuroticism .16 .08 .21 1.89 (.06)  2.35  
Conscientiousness -.06 .09 -.06 -.62 (.54)  1.57  
Step 2  5.05   .13 (<.001)  .39 
Self-efficacy -.55 .21 -.22 -2.61 (.01)  1.36  
Positive beliefs 
about worry 
.16 .19 .08 .82 (.41)  1.87  
Negative beliefs 
about worry 
-.05 .16 -.03 -.30 (.77) 
 
2.12 
 
Intolerance of 
uncertainty 
-.09 .05 -.22 -1.84 (.07) 
 
2.82 
 
Rumination .16 .07 .23 2.37 (.02) 
 
1.87 
 
Reassurance 
seeking 
.06 .06 .08 .92 (.36)  1.60  
Health-related 
reassurance 
seeking 
.19 .08 .20 2.36 (.02) 
 
1.41 
 
Social constraints -.03 .06 -.05 -.52 (.60) 
 
1.60 
 
Note: B = unstandardized regression coefficient; SE = standard error and standard error of the 
estimate for step 1 or step 2; β = standardized regression coefficient; VIF = variance inflation 
factor 
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Assessed for eligibility 
(n= 1,486) 
Consented 
(n = 140) 
Ineligible after consent 
(n = 3) 
Withdrew 
(n = 4) 
Failed to complete measures 
(n = 13) 
 
 
 
 
 
  
 
 
Approached for consent 
(n = 198) 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 
 
Participant flow chart 
Ineligible for participation 
(n = 1,239) 
Unable to be contacted 
(n = 49) 
Completed study measures 
(n = 120) 
Refused to participate 
(n = 41) 
Verbally agreed, no consent 
(n = 17) 
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DISCUSSION 
 
 
 
 
The primary purpose of the current study was to identify modifiable characteristics 
associated with FCR in order to inform the future creation of an intervention for cancer survivors 
experiencing FCR. This was accomplished by first examining non-modifiable and modifiable 
characteristics associated with FCR and then evaluating the relative contributions of modifiable 
and non-modifiable characteristics to FCR. 
Consistent with prior research findings (Simard et al., 2013, McGinty et al., 2012; Savard 
& Ivers, 2013; Crist & Grunfeld, 2013; Koch, Jansen, Brenner & Arndt, 2013; Lahey, 2009), this 
study found significant relationships between non-modifiable characteristics (i.e., demographic, 
clinical and personality characteristics) and FCR, such that patients who were younger, female, 
had worse disease severity and reported greater neuroticism, reported greater FCR. Contrary to 
expectations and prior research findings (McGinty et al., 2012), perceived risk was not 
associated with FCR. Conscientiousness was related to FCR, but not in the direction 
hypothesized. That is, the current study found that those who reported lower conscientiousness, 
reported greater fear of cancer recurrence. This last finding is consistent with a recent study 
among Chinese cancer survivors, which also demonstrated an inverse relationship between 
conscientiousness and FCR (Liao, Yeung, Wong, Warmoth & Lu, 2017).  This study also 
reported that the relationship was mediated by a greater sense of hopelessness. Consistent with 
this idea, research suggests that those low on conscientiousness tend to report a lower internal 
locus of control and are less likely to engage in health behaviors (Christensen, Moran, & Wiebe, 
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1999; Molloy, O’Carroll & Ferguson, 2014). Taken together, these findings suggest that those 
low in conscientiousness may perceive that they have limited ability to influence a cancer 
recurrence and, therefore, experience greater FCR. 
Consistent with hypotheses regarding modifiable characteristics, the current study found 
that cognitive, behavioral and social characteristics were associated with FCR. In regards to 
cognitive characteristics, self-efficacy for preventing a cancer recurrence, positive beliefs about 
worry, negative beliefs about worry, intolerance of uncertainty and rumination were related to 
FCR in the expected direction. That is, survivors who reported heightened FCR, tended to feel 
less confident in their ability to prevent a cancer recurrence, tended to view worry as beneficial 
yet also more dangerous and uncontrollable, tended to be less tolerant of uncertainty and tended 
to report more rumination. Similarly, a recent study by Butow and colleagues (2015) examining 
relationships between metacognitions and FCR found that among breast and prostate cancer 
survivors, those with greater FCR had more positive beliefs about worry (e.g., worrying helps me 
cope) and more negative beliefs about worry (e.g., my worrying is dangerous for me). In 
addition, findings are consistent with a study by McGinty et al. (2016) which showed that lower 
coping self-efficacy was associated with heightened FCR among breast cancer survivors. Among 
novel findings from the current study are results showing that survivors who tend to be less 
tolerant of uncertainty and engage in more rumination reported greater FCR. These finding are 
consistent with the literature on psychological distress in cancer survivors which has shown that 
survivors reporting greater distress tend to be less tolerant of uncertainty (Eisenberg et al., 2014; 
Kurita, Garon, Stanton & Meyerowitz, 2013) and tend to report greater rumination (Galfin & 
Watkins, 2012; Hill & Watkins, 2017). Contrary to hypotheses and prior research (Mehnert, 
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Berg, Henrich & Herschbach, 2009; Lee-Jones, Humphris, Dixon & Hatcher, 1997), 
misinterpretation of symptoms was not related to FCR in the current study. 
Results from the current study demonstrated that behavioral characteristics, including 
threat-related and health-related reassurance seeking were associated with FCR. That is, greater 
threat-related and health-related reassurance seeking were related to greater FCR. These findings 
are consistent with prior research on health anxiety, which emphasizes the importance of 
reassurance seeking in maintaining health anxiety (Furer, Walker & Freeston, 2001; Langlois & 
Ladouceur, 2004). Prior research on FCR suggests that those with greater FCR visit the doctor 
more often (Lebel, 2013; Koch, 2014) and engage in more reassurance seeking behaviors 
(McGinty, Small, Laronga & Jacobsen, 2016). Also consistent with study findings, intervention 
studies targeting reassurance seeking behaviors have demonstrated reductions in FCR (Lebel et 
al., 2014). However, this is the first study to differentiate between threat-related and health- 
related reassurance seeking. 
With regard to social characteristics, greater social constraint was associated with greater 
FCR in the current study. Although no study to date has examined the relationship between 
social constraints and FCR, this is consistent with prior research demonstrating the detrimental 
impact of social constraints on emotional adjustment among cancer survivors (Lepore, 2001; 
Lepore & Revenson, 2007) and a recent study which found that social isolation was related to 
FCR (Koch-Gallenkamp, Bertram, Eberle, Holleczek & Schmid-Hopfner et al., 2016). Contrary 
to expectation, social support was not associated with FCR. Prior research findings on this topic 
are mixed (Crist & Grunfeld, 2013; Thewes, Bell, Butow, Beith, & Boyle et al., 2013). Taken 
together, findings from this study suggest that perceptions of strained interpersonal relationships 
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with important others (i.e., social constraints), rather than lack of social support, contributes to 
greater FCR. 
Findings from multivariate analyses indicated that modifiable characteristics (i.e., 
positive beliefs about worry, negative beliefs about worry, intolerances of uncertainty, threat- 
related reassurance seeking, health-related reassurance seeking and social constraints) accounted 
for approximately 13% of the variance in FCR after controlling for non-modifiable 
characteristics (i.e., age, gender, disease severity, neuroticism and conscientiousness). Among 
the modifiable characteristics in the model, self-efficacy for preventing a cancer recurrence, 
rumination and health-related reassurance seeking accounted for unique variance in FCR, such 
that less self-efficacy for preventing a cancer recurrence, greater rumination and greater health- 
related reassurance seeking were related to greater FCR. These findings are consistent with 
cognitive behavioral models of health anxiety which emphasize the role that reassurance seeking 
behaviors and cognitive processes, such as rumination, play in maintaining health anxiety (Furer, 
Walker & Freeston, 2001; Langlois & Ladouceur, 2004; Norris & Marcus, 2014). These findings 
also lend support to a cognitive processing model of FCR recently proposed by Fardell et al. 
(2016). This model identifies problematic styles of information processing, such as rumination, 
as contributors to heightened FCR, and proposes a bidirectional relationship between heightened 
FCR and emotional, behavioral (e.g., reassurance seeking) and cognitive responses to cancer. 
Other key components of the Fardell model, which are supported by findings from the current 
study, include the crucial role that metacognitions or unhelpful beliefs about worry play in the 
development and maintenance of FCR (Fardell et al., 2016). 
The current study has several strengths. First, it evaluated a theoretical model of 
clinically relevant modifiable contributors to FCR comprised of cognitive, behavioral and social 
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characteristics. Second, this study included both males and females, allowing us to examine 
gender as a potential non-modifiable characteristic impacting FCR and making its findings 
generalizable to both genders. Third, it addressed the general lack of prior research on predictors 
of FCR among colorectal cancer survivors, which is among the most common cancers in U.S. 
adults. 
In addition, several study limitations should be considered. First, this study used a cross- 
sectional design. This feature does not allow causal conclusions to be drawn about relationships 
between FCR and modifiable characteristics. Studies using longitudinal research designs should 
be conducted to examine the temporal direction of these relationships and consider potential 
bidirectional relationships between FCR and cognitive, behavioral and social characteristics in 
order to deepen our conceptual understanding of FCR. Second, due to the homogeneity of race 
and ethnicity in the sample, findings may not generalize to populations of cancer patients with 
more diverse backgrounds. Accordingly, future studies should recruit more heterogeneous 
samples of cancer patients. Third, although the participation rate for this study was relatively 
high (71% of those able to be contacted), it is possible that our sample is not representative of the 
colorectal cancer population. For example, it could be that those with higher levels of FCR chose 
not to participate due to discomfort with questions or their preference to avoid thinking about the 
potential for a recurrence. 
Findings from the present study have numerous implications for clinical practice. First, 
given that approximately 56% of colorectal cancer survivors in the current study met criteria for 
clinically significant FCR, these results suggest that FCR is relatively common among colorectal 
cancer survivors. Therefore, oncologists and mental health professionals treating colorectal 
cancer patients should consider screening for FCR in their patients. Second, these findings can 
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assist clinicians in identifying those patients who might be most in need of an intervention 
designed to address FCR. Results of the current study suggest that this is a particularly relevant 
discussion for those patients who are younger, female, have poorer disease prognosis, report 
greater neuroticism and report lower conscientiousness. Third, the findings regarding modifiable 
characteristics have implications for intervention development. Specifically, they suggest that 
interventions to address FCR should target self-efficacy for preventing a cancer recurrence, 
rumination and health-related reassurance seeking. 
Although no intervention studies have examined self-efficacy for preventing a cancer 
recurrence as a mediator, motivational interviewing and social-cognitive interventions have 
demonstrated positive effects on behavior change via self-efficacy in other populations. For 
example, one study examining the efficacy of a brief motivational interview on drinking 
behaviors found that the relationship between the intervention and heavy drinking was mediated 
by increases in self efficacy (Magill et al., 2017). Another randomized controlled trial evaluating 
a social-cognitive intervention for fruit and vegetable consumption identified self-efficacy as a 
mediator for facilitating dietary changes (Kreausukon, Gellert, Lippke & Schwarzer, 2012). 
Future studies should examine the effects of motivational interviewing and social-cognitive 
interventions for influencing FCR via self-efficacy. 
Cognitive behavioral therapy (CBT), metacognitive therapy (MCT) and mindfulness- 
based approaches have all shown efficacy for targeting rumination in other populations. For 
example, in randomized controlled trials assessing the efficacy of CBT among depressed 
patients, rumination has been shown to mediate improvements in depressive symptoms 
(Teismann, von Brachel, Hanning, Grillenberger, & Hebermehl, et al., 2014; Watkins, Mullan, 
Wingrove, Rimes & Steiner et al., 2011). Although MCT is a relatively novel treatment 
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approach, a recent meta-analysis showed that MCT is effective in reducing rumination, anxiety 
and depression. (Normann, van Emmerik & Morina, 2014). Similarly, randomized controlled 
trials evaluating mindfulness-based interventions among other populations (i.e., lung, cervical 
and breast cancer survivors, depressed patients) have demonstrated beneficial effects on 
psychological distress through the mechanism of rumination (Boyle, Stanton, Ganz, Crespi & 
Bower, 2017; Schellekens, van den Hurk, Prins, Donders, Molema et al., 2017; Shahar, Britton, 
Sbarra, Figueredo & Bootzin, 2010; Shao, Gao & Cao, 2016). It is quite possible that these 
findings may extend to FCR. 
Behavioral therapy and cognitive-existential therapy have shown efficacy for targeting 
reassurance seeking behaviors. A study conducted by Weck and colleagues (2014) which 
compared the effectiveness of cognitive therapy and exposure therapy in treating health anxiety, 
found that those who underwent exposure therapy were significantly less likely to engage in 
safety behaviors (i.e., reassurance seeking, body checking). A similar randomized controlled trial 
of behavioral therapy (applied relaxation versus worry exposure) in GAD patients, demonstrated 
beneficial treatment effects via reductions in reassurance seeking behaviors (Beesdo-Baum, 
Jenjahn, Hofler, Leuken, Becker & Hoyer, 2012). 
In conclusion, the current study adds to the literature on FCR by identifying non- 
modifiable and modifiable factors related to FCR and distinguishing those modifiable factors 
which uniquely explain variance in FCR. Specifically, this study found that when accounting for 
non-modifiable factors (i.e., age, gender, disease severity, neuroticism and conscientiousness), 
modifiable factors (i.e., self-efficacy, positive beliefs about worry, negative beliefs about worry, 
intolerance of uncertainty, rumination, reassurance seeking, health-related reassurance seeking 
and social constraints) significantly contribute to variance in FCR, with self-efficacy, health- 
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related reassurance seeking and rumination contributing unique variance. These findings provide 
support for a cognitive behavioral model of FCR and suggest that FCR interventions target self- 
efficacy, health-related reassurance seeking and rumination. 
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